PHARMAnetwork magazine covers, every aspect of pharmaceutical value chain in the intersection between pharmaceutical industry and outsourcing industry.
Novavax is delaying signing a contract to supply its COVID-19 vaccine to the European Union, an EU official involved in the talks told Reuters, as the U.S. biotech company warned it was struggling to source some raw materials. https://t.co/QbsDJJdi9m
European Union export restrictions on COVID-19 vaccines would result in a 'lose-lose' situation for everyone, including EU members, a Pfizer executive said, a day after the bloc tightened oversight of shot deliveries beyond its borders. https://t.co/9l2LumhsN6
We pursue our efforts in #vaccines production capacity.
On the ground, there is an acceleration:
✔️14m doses in January
✔️28m in February
✔️60m in March
By Q2, we will be at 100 million per month.
On track to have 70% of the 🇪🇺 population vaccinated by the end of summer.
The European Commission has ordered 1,860 million doses for the first four vaccines against #covid. Why are they reaching us with delay, in spite of the european industrial capacities of #FillandFinish? Explanations on @PHARMAnetwork: https://t.co/T8Ff9p43LG
We just announced a supply update for the Moderna COVID-19 Vaccine in the United States, reporting that 45.4 million doses have been supplied to the U.S. Government to date. Read more: https://t.co/DKsKY86RCD
Demand for anti-#COVID19 vaccines is much higher than the production capacities of western countries: what an exceptional driver for #CDMO. Discover agreements between Big pharma, biotechs and #CDMO on our latest report just here: https://t.co/f5uztraKLp.
In the November issue of PHARMAnetwork magazine, discover our files:
"#Biomanufacturingg: Supersized investments”
"#Vaccinee against #Covid-19 - what responsibilities
in the event of side effects?”
PHARMAnetwork magazine https://t.co/vpkegZYNXd
In the
January issue of PHARMAnetwork magazine, discover our file:
« Impact of new MAs on organic growth for CDMOs”
Read all the articles in this issue of PHARMAnetwork magazine on the online version at the web address: https://t.co/vpkegZYNXd
PHARMAnetwork magazine – January issue – n36
. Recipharm: “the evolution of the CDMO market and our place within it”..
. Update on the serialization process in Europe.
PHARMAnetwork magazine
is available on PC, tablets and smartphones
https://t.co/NRRVbQqcZ3